Infectious Disease Condition Center Debuts

Published Online: Friday, November 9, 2012
Follow Pharmacy_Times:
This month, we introduce a new condition center on www.PharmacyTimes.com covering infectious disease. Visit it for the latest news and research on the prevention, development, and treatment of conditions such as influenza, otitis media, pharyngitis, and tonsillitis.

Some features of the condition center include:
  • An article on a review of recent studies finding statistically significant advantages of antibiotics in treating acute otitis media in young children.
  • An article on updated flu vaccine guidelines for children from the American Association of Pediatrics.
  • A video interview with Doug Long, vice president of industry relations at IMS Health, on his predictions for the 2012-2013 flu season.


Related Articles
Even though kids with neurological disorders are at high risk for flu-related complications, they are no more likely to receive annual flu vaccination than healthy children.
Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.
The FDA has granted 2 breakthrough therapy designations to grazoprevir/elbasvir.
Finding relief is a top priority for anyone experiencing the pain and discomfort often associated with a sore throat, or pharyngitis.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$